Biological Drugs Raise Concerns about Their Safety
A group of Dutch researchers have reported that about one fourth of the biological drugs that had hit the United States and Europe markets since 1995 had given rise to concerns about their safety just a few years after they had been approved.
Derived from living cells (and not from various chemicals like the typical drugs are), the biological meds have prompted safety warnings with regards to immune system disorders, infusion reactions, infections and cancer risk.